There’s a new CBD coalition in town
Monday marked the official launch of the Collaborative for CBD Science & Safety, a coalition group that includes makers of CBD drugs and dietary supplements, patient groups, and even some outspoken CBD skeptics.
Early signs show the group, which is run out of the law firm Faegre Drinker, is likely to take a skeptically cautious view toward CBD products that haven’t gone through the FDA approval process: Its members include Greenwich Biosciences, the only company which has pushed a CBD-based drug through the FDA approval process; the Council for Responsible Nutrition, which represents CBD supplement makers like CV Sciences and Oleo; and the National Consumers League, which launched it’s own initiative late last year warning consumers about the dangers of unvetted CBD products.
Libby Baney, a partner at Faegre Drinker and the secretariat of the new group, described the group’s common interest this way: “Research is really important, science really matters. ... Allowing the Wild West of unregulated supplement market, as currently exists, really puts patients in the backseat.”
The group has not yet registered to lobby, but likely will do so, according to Baney.
In other CBD news …
The Drug Enforcement Administration has descheduled Epidiolex, the FDA-approved CBD medication used to treat seizure disorders. The change will make it easier for patients to fill prescriptions and will allow doctors to prescribe the drug without taking part in state prescription monitoring programs, according to a company press release. Less than two years ago, the drug was considered a Schedule I drug, along with drugs like heroin and LSD.
Early signs show the group, which is run out of the law firm Faegre Drinker, is likely to take a skeptically cautious view toward CBD products that haven’t gone through the FDA approval process: Its members include Greenwich Biosciences, the only company which has pushed a CBD-based drug through the FDA approval process; the Council for Responsible Nutrition, which represents CBD supplement makers like CV Sciences and Oleo; and the National Consumers League, which launched it’s own initiative late last year warning consumers about the dangers of unvetted CBD products.
Libby Baney, a partner at Faegre Drinker and the secretariat of the new group, described the group’s common interest this way: “Research is really important, science really matters. ... Allowing the Wild West of unregulated supplement market, as currently exists, really puts patients in the backseat.”
The group has not yet registered to lobby, but likely will do so, according to Baney.
In other CBD news …
The Drug Enforcement Administration has descheduled Epidiolex, the FDA-approved CBD medication used to treat seizure disorders. The change will make it easier for patients to fill prescriptions and will allow doctors to prescribe the drug without taking part in state prescription monitoring programs, according to a company press release. Less than two years ago, the drug was considered a Schedule I drug, along with drugs like heroin and LSD.
.png)
No hay comentarios:
Publicar un comentario